Mylan N V (MYL) Return on Investment ROI from the third quarter of 2020 to third quarter of 2019 and for the year 2020, average high and low, overall ranking from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mylan N v   (NASDAQ: MYL)


Mylan N V's ROI from its third quarter of 2020 to the third quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Mylan N V's ROI in the third quarter of 2020?
Mylan N v achieved a return on average invested assets (ROI) of 1.16 % in its third quarter of 2020, which is below Mylan N V's average return on investment, which stands at 3.47%.

ROI has improved compared to 1.13% in the second quarter of 2020, due to net income growth.

Within the Healthcare sector 166 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2020 from 1885 to 2010.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Investment Change TTM -16.3 % -14.23 % -10.13 % -7.08 % -4.65 %
Y / Y Net Income Change TTM 460.84 % 686.34 % -69.15 % -92.63 % -73.12 %
Investment (TTM) in Millions 22,550 21,642 23,380 24,169 26,409
Return On Investment (TTM) 1.16 % 1.13 % 0.25 % 0.06 % 0.17 %
MYL's Overall Ranking # 2010 # 1885 # 1995 # 2637 # 0
Seq. Investment Change TTM -4.04 % -5.55 % -4.17 % -3.63 % -1.67 %
Seq. Net Income Change TTM -1.52 % 332.11 % 272.62 % -64.63 % 38.08 %
Net Income (TTM) in Millions 266 271 63 17 48

MYL Company Profile >> Back to MYL Roi Comparisons >> See Annual MYL Return On Investment



Return On Investment MYL's Ranking
Within: No.
Industry # 53
Sector # 167
Overall # 2010

Return On Investment Statistics
High Average Low
19.8 %
3.47 %
-23.87 %
  (Dec. 31. 2007)







Financial Statements
Mylan N V's III. Quarter Investments $ 22,550 Millions MYL's Balance sheet
Mylan N V's III. Quarter Income $ 186 Millions Quarterly MYL's Income Statement
MYL's Income by Division See MYL's Income by Division


MYL Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 25,686 28,147 29,421 29,687 18,147
Y / Y Investment Growth -8.74 % -4.33 % -0.9 % 63.59 % 71.51 %
Net Income in Millions 17 353 696 480 848
Y / Y Net Income Growth -95.23 % -49.35 % 45 % -43.38 % -8.79 %
Annual Return On Investment 0.07 % 1.25 % 2.37 % 1.62 % 4.67 %


Annual Roi Comment
In the fiscal year 2019 ROI decreased relative to the previous year to 0.07 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MYL's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MYL's Competitors
Subscribers only: Roi for Mylan N V's Suppliers
Subscribers only: Return On Investment for MYL's Customers

Other Ratios
MYL's Roa MYL's Inventory Turnover Ratio MYL's Growth Rates MYL's Dividend Statistics
MYL's Profitability Ratios MYL's Asset Turnover Ratio MYL's Dividend Growth
MYL's Roe MYL's Valuation Ratios MYL's Financial Strength Ratios MYL's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2020, within Healthcare Sector ROI
Repligen Corp  3.13 %
Integer Holdings Corporation  3.03 %
Progyny Inc   2.84 %
Heartbeam Inc   2.69 %
Harmony Biosciences Holdings inc   2.65 %
The Pennant Group Inc   2.49 %
Gilead Sciences Inc   2.47 %
National Healthcare Corp  2.34 %
Eagle Pharmaceuticals inc   2.32 %
Insulet Corporation  2.31 %
Becton Dickinson And Company  1.87 %
Cantel Medical Corp   1.78 %
Avanos Medical Inc   1.69 %
Integra Lifesciences Holdings Corp  1.60 %
Acadia Healthcare Company Inc   1.56 %
Avantor Inc   1.55 %
Tenet Healthcare Corp  1.46 %
Amphastar Pharmaceuticals Inc   1.39 %
Mylan N v   1.11 %
Iqvia Holdings Inc   0.98 %
Surmodics Inc   0.77 %
Enovis Corp  0.71 %
Agape Atp Corporation  0.61 %
Brookdale Senior Living Inc   0.54 %
Amneal Pharmaceuticals Inc   0.32 %
National Vision Holdings Inc   0.26 %

Date modified: 2026-09-26T06:50:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.